Polycystic Ovary Syndrome (PCOS)

News

hcp.obgyn.net - 1/31/11



EventCalendar

OBGYN.net -
by Paragon Conventions
OBGYN.net -
by World Class CME
OBGYN.net -
by Fundacio Dexeus Salud de la Mujer
OBGYN.net -
by International Osteoporosis Foundation
OBGYN.net -
by National University Hospital (NUH)

ConnectWithUs

 Become a fan on
 Facebook
 Add us on
 Google Plus
 Follow us on
 Twitter
 Join our
 LinkedIn group
 Watch our
 videos on
 YouTube
 Sign up for our
 Newsletters
 Subscribe to our
 RSS Feed

 

LatestFeatures

Polycystic Ovary Syndrome... Treatment with Insulin Lowering Medications
Polycystic ovary syndrome is characterized by anovulation (irregular or absent menstrual periods) and hyperandrogenism (elevated serum testosterone and androstenedione). More »
Polycystic Ovary Syndrome (POCS)
The polycystic ovary syndrome (PCOS) is a condition in which the ovaries accumulate tiny "cysts" (actually little follicles, two to five millimeters in diameter, each of which contains an egg) More »
An Introduction to Polycystic Ovary Syndrome
What exactly is Polycystic Ovary Syndrome? Physicians are taught that the syndrome is best described as "hyperandrogenic anovulation." More »
Polycystic Ovary Syndrome
Polycystic Ovarian Syndrome (PCOS) is one of the most common hormonal diseases affecting reproductive-aged women. In actuality, PCOS includes a spectrum of disorders rather than a single, discrete disease. More »
Prevalence of Non-alcoholic Fatty Liver Disease in Polycystic Ovary Syndrome
The prevalence of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome (PCOS) has not been previously described. As insulin resistance has been implicated in the pathogenesis of both NAFLD and PCOS, we hypothesized that NAFLD would be common in PCOS. More »
A Patient’s Guide: Management of Hair Loss in Polycystic Ovary Syndrome
Thinning hair due to the effects of male hormones (androgens) is called androgenic alopecia. It is a major source of psychological distress to women. This male-pattern hair loss is often seen in women with polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia, and other disorders of male hormone excess. More »
Conception Rate in Polycystic Ovary Syndrome
Polycystic ovary syndrome is characterized by enlarged ovaries, multiple peripherally arranged cysts and increased stromal density(1). Polycystic ovary syndrome is responsible for approximately 25-30% of infertility in women, which is mainly anovulatory(2). Ovulation can be induced with antiesterogens in many women but a proportion fail to respond and even in those who ovulate, the pregnancy rate is often low and the miscarriage rate is high. More »
Polycystic Ovary Syndrome: Treatment with Insulin Lowering Medications
Polycystic ovary syndrome is characterized by anovulation (irregular or absent menstrual periods) and hyperandrogenism (elevated serum testosterone and androstenedione). Patients with this syndrome may complain of abnormal bleeding, infertility, obesity, excess hair growth, hair loss and acne. More »
Showing 1 - 8 of 18 results.
Page of 3

FromtheJournals

pubmed.gov - 11/1/10
To review the etiology and incidence of and associative factors in the formation of adhesions following gynaecological surgery. To review evidence for the use of available means of adhesion prevention following gynaecological surgery.|Women undergoing pelvic surgery are at risk of developing abdominal and/or pelvic adhesive disease postoperatively. Surgical technique and commercial adhesion prevention systems may decrease the risk of postoperative adhesion formation.|The outcomes measured are the incidence of postoperative adhesions, complications related to the formation of adhesions, and further intervention relative to adhesive disease.|Medline, EMBASE, and The Cochrane Library were searched for articles published in English from 1990 to March 2009, using appropriate controlled vocabulary and key words. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, cohort studies, and meta-analyses specifically addressing postoperative adhesions
pubmed.gov - 3/1/11
The optimal technique for performing caesarean section with respect to minimising postoperative adhesions has not been determined.|To evaluate adhesion formation for three common caesarean section techniques in women undergoing repeat caesarean section surgeries.|A database was constructed from Medline, EMBASE, Cochrane Library, National Science Digital Library, China Biological Medicine Database and through contact with experts in this field from January 1990 to May 2010.|Studies were included if they examined adhesion formation in repeat caesarean sections as a primary objective, delineated a clear study design, specified an adhesion scoring system, and had sufficient patient exclusion criteria.|We abstracted data regarding adhesion formation. The Mantel-Haenszel random-effects model was employed for all analyses using odds ratio or inverse variance, along with 95% CI.|Thirty-three qualified studies including 4423 women were analysed. There were 406 adhesions among 571 women and 238
pubmed.gov - 6/1/10
To review the etiology and incidence of and associative factors in the formation of adhesions following gynaecological surgery. To review evidence for the use of available means of adhesion prevention following gynaecological surgery.|Women undergoing pelvic surgery are at risk of developing abdominal and/or pelvic adhesive disease postoperatively. Surgical technique and commercial adhesion prevention systems may decrease the risk of postoperative adhesion formation.|The outcomes measured are the incidence of postoperative adhesions, complications related to the formation of adhesions, and further intervention relative to adhesive disease.|Medline, EMBASE, and The Cochrane Library were searched for articles published in English from 1990 to March 2009, using appropriate controlled vocabulary and key words. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, cohort studies, and meta-analyses specifically addressing postoperative adhesions
pubmed.gov - 5/1/07
To investigate the role of hyaluronic acid-based fluid agents in the prevention of adhesions after fertility-preserving gynecological surgery.|Meta-analysis.|The authors searched the Cochrane Menstrual Disorders and Subfertility Group Specialized Register of Controlled Trials, The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE for randomized controlled trials of hyaluronic acid fluid agents compared with no treatment or placebo.|Women undergoing fertility-preserving gynecological surgery.|Hyaluronic acid fluid agents.|[1] Prevalence and change in adhesion severity at second-look laparoscopy and [2] live birth rate.|Four studies were included in the meta-analysis. The use of hyaluronic acid agents was associated with a decrease in the prevalence of adhesions at second-look laparoscopy (odds ratio, 0.31; 95% confidence interval, 0.19 to 0.51) and a lesser chance of deterioration of preexisting adhesions (odds ratio, 0.28; 95% confidence interval, 0.12 to 0.66).
pubmed.gov - 1/1/08
Pelvic adhesion can form as a result of inflammation, endometriosis or surgical trauma. During pelvic surgery, strategies to reduce pelvic adhesion formation may include placing synthetic barrier agents such as oxidised regenerated cellulose, polytetrafluoroethylene or Fibrin sheets between the pelvic structures.|To assess the effect of physical barriers used during pelvic surgery in women of reproductive age on pregnancy rates, pelvic pain, or postoperative adhesion reformation.|We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (searched September 2007) which is based on regular searches of MEDLINE, EMBASE, CINAHL, PsycINFO and CENTRAL, plus handsearching of 20 relevant journals and conference proceedings, and searches of several key grey literature sources. In addition, companies were contacted for unpublished trials.|Any randomised controlled trials (RCTs) comparing the use of physical barriers versus no treatment or other physical barriers in the

ClinicalTrials

www.clinicaltrials.gov - 8/22/11
commonly performed in Obstetrics and Gynecology Clinics. Complications related ... incision after C/S (adhesions separation (dehiscence) ...
www.clinicaltrials.gov - 8/20/10
(i.e. large submucous fibroids uterine adhesions apparent uni or bilateral proximal ... Valaoras & Lewis Obstetrics and Gynecology Winston-Salem North Carolina United ...
www.clinicaltrials.gov - 8/4/10
thereby excluding anatomical abnormalities intrauterine adhesions and cervical incompetence; ... Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine ... János Rigó Prof. Gynecology and Obstetrics Dept Semmelweis University Budapest Hungary ...
www.clinicaltrials.gov - 7/21/10
uterine stent to prevent intrauterine adhesion (IUA) ... In order to prevent adhesion reformation after surgery most gynecologists ... Department of Obstetrics and Gynecology Shin-Kong Wu-Ho-Su Memerial Hospital ...
www.clinicaltrials.gov - 1/13/10
A laparoscopy that demonstrated pelvic adhesions or stage I or II ... Chair Department of Obstetrics and Gynecology Dartmouth-Hitchcock Medical Center Dartmouth ...

PracticeGuidelines

www.sogc.org -
SOGC CLINICAL PRACTICE GUIDELINE Adhesion Prevention in Gynaecological Surgery Abstracts Objectives: To review the etiology and incidence of and associative factors in the formation of adhesions following gynaecological surgery. ... To review evidence
www.sogc.org -
Outcomes: Implementation of this guideline should optimize the decision-making process of women and their health-care providers in proceeding with further investigation or therapy for uterine leiomyomas, having considered the ... For the symptomatic
www.sogc.org -
SOGC Clinical Practice Guideline Ovulation Induction in Polycystic Ovary Syndrome Abstract Objective: To review current non-pharmacologic and pharmacologic options for ovulation induction in women with polycystic ovary syndrome ( PCOS). ... Weight loss,

PatientResources

ww5.komen.org -
ligands and measure PAI-1, uPA, and uPAR levels; and perform adhesion, proliferation, and migration assays; 2) To treat tumorigenic and non-tumorigenic breast cancer cell lines with natural PPAR? ... ligands and measure PAI-1, uPA, and uPAR levels; and
www.nlm.nih.gov -
Preventing urinary tract infections ( UTIs). Research shows that drinking cranberry juice cocktail can help prevent repeated UTIs in older women and pregnant women.
www.nlm.nih.gov -
Un servicio de laBusque en MedlinePlus. Arndano ( agrio, rojo). Para usar las funciones de compartir de esta pginas, por favor, habilite JavaScript. Qu es? El arndano rojo es un arbusto pequeo que crece en toda Norteamrica. El
www.niaid.nih.gov -
04-4697 February 2004 www.niaid.nih.gov Womens Health i n t h e U. ... DEPARTMENT OF HEALTH AND HUMAN SERVICES. Womens Health i n t h e U.
www.ahrq.gov -
asymptomatic women, women with suspected ovarian cancer, and women with diagnosed ovarian cancer; ( d) the harms of genomic testing; and ( e) the impact of direct-to-consumer and direct-to-physician ... We found no evidence relevant to the question of

MedicalProfessionalForum

forums.obgyn.net - 10/3/11
title: OB-GYN-L Messages: Re: Million Med March State by State Information and request for ...
Dr Eberhard Lisse: "Re: Million Med March State by State Information and request for" Previous message: ...
forums.obgyn.net - 10/3/11
title: OB-GYN-L Messages: Toxoplasmosis confirmation ...
YankowitzJ@obgyn-po.obgyn.uiowa.edu: "Re: Toxoplasmosis confirmation" Maybe reply: ...
forums.obgyn.net - 10/3/11
OB-GYN-L Messages by date Messages sorted by: [ thread ][ subject ][ author ] Return to archive index ...
forums.obgyn.net - 10/3/11
title: OB-GYN-L Messages: Re: factor V ...
32nd annual international meeting of the Czech Ultrasound Society in Obstetrics and Gynecology by Czech Society for Ultrasound in Obstetrics and Gynecology ...
forums.obgyn.net - 10/3/11
title: OB-GYN-L Messages: Re: GYN: Business question modifier 22. ...
32nd annual international meeting of the Czech Ultrasound Society in Obstetrics and Gynecology by Czech Society for Ultrasound in Obstetrics and Gynecology ...